Kisan Injection is used to treat or prevent bleeding caused by severe hypoprothrombinemia.
Understanding Hypoprothrombinemia
Hypoprothrombinemia is a condition characterized by a deficiency of certain blood clotting factors, specifically factors II, VII, IX, and X. This deficiency can lead to excessive bleeding or the risk of bleeding.
Causes of Hypoprothrombinemia
Several factors can contribute to hypoprothrombinemia, including:
- Overdosage of anticoagulants: Medications like dicoumarol and its combinations with phenylbutazone can sometimes excessively reduce blood clotting, leading to hypoprothrombinemia.
- Hypovitaminosis K: Deficiency in Vitamin K can impair the production of clotting factors, resulting in hypoprothrombinemia. This can occur due to:
- Dietary deficiencies
- Conditions that prevent vitamin K absorption
How Kisan Injection Helps
Kisan Injection works by addressing the deficiency in the mentioned clotting factors that result from hypoprothrombinemia. By providing these essential factors, the injection aids in restoring the blood's ability to clot normally, preventing or controlling haemorrhage.
Examples of Conditions Treated with Kisan Injection:
- Bleeding from anticoagulant overdose: If a patient is taking anticoagulants and experiences severe bleeding, Kisan Injection can help reverse the anticoagulant's effects by providing the deficient clotting factors.
- Threatened hemorrhage due to Vitamin K deficiency: When bleeding risk increases because of low levels of Vitamin K, Kisan Injection can be used to supplement the needed clotting factors.
Key Benefits of Kisan Injection:
- Stops Bleeding: Helps to stop or prevent ongoing bleeding.
- Restores Clotting: Reintroduces necessary clotting factors.
- Addresses Underlying Issues: Specifically targets issues resulting from severe hypoprothrombinemia.
| Condition | Description |
|---|---|
| Hypoprothrombinemia | A deficiency in blood clotting factors II, VII, IX, and X |
| Overdosage of anticoagulants | Excessive intake of medications that reduce blood clotting, such as dicoumarol or its combination with phenylbutazone, leading to increased bleeding risk |
| Hypovitaminosis K | Deficiency of Vitamin K leading to reduced production of blood clotting factors, resulting in increased bleeding risk |
